Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2025016949
Abstract: Key Points • Dose modifications in DREAMM-7 and DREAMM-8 led to less frequent belamaf dosing in later periods of treatment.• Ocular events were managed by belamaf dose modifications, which allowed for continuation of treatment and… read more here.
Keywords: dreamm; modification belantamab; efficacy; mafodotin dosing ... See more keywords